Interleukin Genetics Secures Approval in New York State to Offer PerioPredicta

Interleukin Genetics, Inc. today announced it has received conditional approval from the New York State Department of Health to offer, process and report the results of the PerioPredicta Genetic Risk Test for periodontal disease.

http://ift.tt/1twR97Q